跳至主要内容
临床试验/NCT06294665
NCT06294665招募中1 期

Comparison Between Bupivacaine-Dexmedetomidine Versus Bupivacaine-Dexamethasone in Pericapsular Nerve Group (PENG) Block as Post-operative Analgesia in Hip Surgeries.

Ain Shams University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
招募中
入组人数
60
试验地点
1
主要终点
The time to the first request of analgesia

研究概览

简要总结

The aim of this work is to compare the effectiveness of bupivacaine- dexmedetomidine mixture versus bupivacaine-dexamethasone mixture in PENG Block as Post-operative Analgesia in Hip surgeries

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-65 years.
  • Sex: Both sexes.
  • American Society of Anaesthesiologists (ASA) Physical Status Class I and II.
  • Scheduled for hip surgeries under spinal anaesthesia.

排除标准

  • Declining to give written informed consent.
  • History of allergy to the medications used in the study.
  • Contraindications to regional anesthesia (including patient refusal, coagulopathy and local infection).
  • Psychiatric disorder.
  • American Society of Anesthesiologists (ASA) Physical Status Class III and IV.

研究组 & 干预措施

Group A : ( Bupivacaine + Dexmedetomidine )

Active Comparator

Group A : will receive bupivacaine 0.25% + dexmedetomidine 1 mic/kg, total volume (20 ml)

干预措施: Pericapsular Nerve Group (PENG) Block (Drug)

Group B: ( Bupivacaine + Dexamethasone )

Active Comparator

Group B : will receive bupivacaine 0.25% +dexamethasone (8 mg), total volume(20 ml).

干预措施: Pericapsular Nerve Group (PENG) Block (Drug)

结局指标

主要结局

The time to the first request of analgesia

时间窗: 9 months

The time interval between the onset of the local infiltration done at the end of the operation and the first request to postoperative analgesia.

次要结局

  • Total doses of analgesia (Nalbuphine) given to patients in 24 hours postoperatively(9 months)
  • Occurrence of side effects of drugs.(9 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验